These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34204103)

  • 21. Apoptotic death of cancer stem cells for cancer therapy.
    He YC; Zhou FL; Shen Y; Liao DF; Cao D
    Int J Mol Sci; 2014 May; 15(5):8335-51. PubMed ID: 24823879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against cancer by dietary IP6 and inositol.
    Vucenik I; Shamsuddin AM
    Nutr Cancer; 2006; 55(2):109-25. PubMed ID: 17044765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine kinases as molecular targets to inhibit cancer progression and metastasis.
    Cepero V; Sierra JR; Giordano S
    Curr Pharm Des; 2010; 16(12):1396-409. PubMed ID: 20166985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the β-catenin signaling for cancer therapy.
    Zhang X; Wang L; Qu Y
    Pharmacol Res; 2020 Oct; 160():104794. PubMed ID: 32278038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The nervous system: a new target in the fight against cancer.
    Kazi R; Bunimovich YL
    Anticancer Drugs; 2018 Nov; 29(10):929-934. PubMed ID: 30239424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repositioning metformin for cancer prevention and treatment.
    Quinn BJ; Kitagawa H; Memmott RM; Gills JJ; Dennis PA
    Trends Endocrinol Metab; 2013 Sep; 24(9):469-80. PubMed ID: 23773243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating metformin for cancer prevention and treatment: the end of the beginning.
    Pollak MN
    Cancer Discov; 2012 Sep; 2(9):778-90. PubMed ID: 22926251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.
    Kaempfen S; Neumann RP; Jost K; Schulzke SM
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011893. PubMed ID: 29499081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WNT signalling pathways as therapeutic targets in cancer.
    Anastas JN; Moon RT
    Nat Rev Cancer; 2013 Jan; 13(1):11-26. PubMed ID: 23258168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
    Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-adrenergic blocker inhibits oral carcinogenesis and reduces tumor invasion.
    Cecilio HP; Valente VB; Pereira KM; Kayahara GM; Furuse C; Biasoli ÉR; Miyahara GI; Oliveira SHP; Bernabé DG
    Cancer Chemother Pharmacol; 2020 Nov; 86(5):681-686. PubMed ID: 32980903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the VEGF signaling pathway in cancer therapy.
    Waldner MJ; Neurath MF
    Expert Opin Ther Targets; 2012 Jan; 16(1):5-13. PubMed ID: 22239434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [β-blockers: a new and emerging treatment for melanoma].
    De Giorgi V; Gandini S; Grazzini M; Benemei S; Marchionni N; Geppetti P
    Recenti Prog Med; 2012 Jan; 103(1):11-6. PubMed ID: 22322621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-tumor effect of aspirin: What we know and what we expect.
    Ma J; Cai Z; Wei H; Liu X; Zhao Q; Zhang T
    Biomed Pharmacother; 2017 Nov; 95():656-661. PubMed ID: 28881293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plant-derived anticancer agents - curcumin in cancer prevention and treatment.
    Creţu E; Trifan A; Vasincu A; Miron A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1223-9. PubMed ID: 23700916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of TGFβ signaling and its implications in anticancer treatments.
    Calone I; Souchelnytskyi S
    Exp Oncol; 2012; 34(1):9-16. PubMed ID: 22453142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytodifferentiation: a novel approach to cancer treatment and prevention.
    Garattini E; Terao M
    Curr Opin Pharmacol; 2001 Aug; 1(4):358-63. PubMed ID: 11710733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin targets multiple signaling pathways in cancer.
    Lei Y; Yi Y; Liu Y; Liu X; Keller ET; Qian CN; Zhang J; Lu Y
    Chin J Cancer; 2017 Jan; 36(1):17. PubMed ID: 28126011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The convergence of cancer prevention and therapy in early-phase clinical drug development.
    Abbruzzese JL; Lippman SM
    Cancer Cell; 2004 Oct; 6(4):321-6. PubMed ID: 15488755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.